Search Results - "Liu, Yen-Chun"

Developmental Pathways of Immature CD11c + Myeloid Dendritic Cells (mDCs) for Bona Fide Osteoclastogenesis Revisited: A Narrative Review.

Authors: Liu, Yen Chun G. Liang, Chen-Yi Teng, Andy Yen-Tung

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p480. 15p.

Chronic myelomonocytic leukemia (CMML): a genetically heterogeneous entity.

Authors: Liu, Yen-Chun van Besien, Koen W.

Source: Leukemia & Lymphoma. Aug2025, Vol. 66 Issue 8, p1359-1361. 3p.

High-Power Impulse Magnetron Sputter-Deposited Chromium-Based Coatings for Corrosion Protection.

Authors: Liu, Yen-Chun Hsiao, Shih-Nan Chen, Ying-Hung et al.

Source: Coatings (2079-6412); Dec2023, Vol. 13 Issue 12, p2101, 17p

Semiparametric estimation of the transformation model by leveraging external aggregate data in the presence of population heterogeneity.

Authors: Cheng, Yu‐Jen Liu, Yen‐Chun Tsai, Chang‐Yu et al.

Source: Biometrics; Sep2023, Vol. 79 Issue 3, p1996-2009, 14p

Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents.

Authors: Kao, Yu-Ting Liu, Yen-Chun Cheng, Ya-Ting et al.

Source: Viruses (1999-4915). Sep2024, Vol. 16 Issue 9, p1485. 13p.

Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.

Authors: van den Akker, Tayler A. Liu, Yen-Chun Liu, Huifei et al.

Source: Pathobiology. 2024, Vol. 91 Issue 1, p89-98. 10p.

Discussion of "Some statistical challenges in automated driving systems".

Authors: Banks, David Liu, Yen‐Chun

Source: Applied Stochastic Models in Business & Industry. Sep2023, Vol. 39 Issue 5, p653-656. 4p.

Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection.

Authors: Liu, Yen‐Chun Jeng, Wen‐Juei Chien, Rong‐Nan

Source: Alimentary Pharmacology & Therapeutics. Oct2023, Vol. 58 Issue 7, p731-732. 2p.

Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance.

Authors: Keng, Hsiang‐Ting Liu, Yen‐Chun Jeng, Wen‐Juei

Source: Alimentary Pharmacology & Therapeutics. Jun2026, p1. 2p.

Editorial: considerations for expanding treatment in grey zone chronic hepatitis B patients.

Authors: Liu, Yen‐Chun Jeng, Wen‐Juei

Source: Alimentary Pharmacology & Therapeutics. Mar2023, Vol. 57 Issue 5, p577-578. 2p.

Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals.

Authors: Liu, Yen‐Chun Jeng, Wen‐Juei Peng, Chien‐Wei et al.

Source: Alimentary Pharmacology & Therapeutics. Mar2024, Vol. 59 Issue 6, p762-773. 12p.

Distinct cross talk of IL-17 & TGF-β with the immature CD11c⁺TRAF6^(-/-)-null myeloid dendritic cell-derived osteoclast precursor (mDDOCp) may engage signaling toward an alternative pathway of osteoclastogenesis for arthritic bone loss in vivo

Authors: Liu, Yen Chun G. Yen-Tung Teng, Andy

Source: Immunity, Inflammation & Disease. Feb2024, Vol. 12 Issue 2, p1-15. 15p.

Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.

Authors: Liu, Yen-Chun Geyer, Julia T.

Source: Pathobiology. 2024, Vol. 91 Issue 1, p30-44. 15p.

Letter: the probability of predicting HBV‐specific CD8+ cell response derived from HLA‐A2+ may not closely predict functional cure in Asian patients who stop nucleoside analogues.

Authors: Liu, Yen‐Chun Jeng, Wen‐Juei

Source: Alimentary Pharmacology & Therapeutics. Oct2022, Vol. 56 Issue 8, p1310-1311. 2p. 1 Chart.

Editorial: is functional cure the only holy grail for treatment discontinuation in patients with HBeAg‐negative chronic hepatitis B?

Authors: Liu, Yen‐Chun Jeng, Wen‐Juei

Source: Alimentary Pharmacology & Therapeutics. Aug2022, Vol. 56 Issue 3, p544-545. 2p.

METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.

Authors: Liu, Yen-Chun Chen, Yu-Jen Wu, Guang-Jer

Source: International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 21, p13389. 17p.

Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals.

Authors: Hsu, Cheng-Er Liu, Yen-Chun Cheng, Ya-Ting et al.

Source: Viruses (1999-4915). Apr2022, Vol. 14 Issue 4, pN.PAG-N.PAG. 10p.

Off‐tenofovir hepatitis flares in HBeAg‐negative patients occur earlier, more frequent and severe than those off‐entecavir therapies.

Authors: Liu, Yen‐Chun Jeng, Wen‐Juei Peng, Chien‐Wei et al.

Source: Liver International. Mar2022, Vol. 42 Issue 3, p551-560. 10p. 4 Charts, 2 Graphs.

From GWAS to drug screening: repurposing antipsychotics for glioblastoma.

Authors: Lin, Wei-Zhi Liu, Yen-Chun Lee, Meng-Chang et al.

Source: Journal of Translational Medicine. 2/4/2022, Vol. 20 Issue 1, p1-13. 13p.

A CTNNB1‐altered medulloblastoma shows the immunophenotypic, DNA methylation and transcriptomic profiles of SHH‐activated, and not WNT‐activated, medulloblastoma.

Authors: Chiang, Jason Moreira, Daniel C. Pytel, Nicholas J. et al.

Source: Neuropathology & Applied Neurobiology. Aug2022, Vol. 48 Issue 5, p1-4. 4p.